BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
XBiotech Launching Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus 5/28/2015 6:42:43 AM
XBiotech USA (XBIT) Successfully Clones First Anti-Ebola Therapeutic Antibody Product Candidate 5/27/2015 7:08:36 AM
XBiotech USA (XBIT) Secures Approval From Data Safety Monitoring Board To Continue Phase III Registration Study In Europe For Its Novel Cancer Immunotherapy 5/18/2015 7:38:39 AM
XBiotech USA (XBIT) Enrolls First Patient Under Revised Protocol For U.S. Phase III Registration Study Using Xilonix For Treatment Of Metastatic Colorectal Cancer 4/29/2015 7:25:35 AM
XBiotech USA (XBIT) Closes IPO 4/17/2015 2:47:10 PM
XBiotech USA, Inc. Announces Pricing Of Initial Public Offering 4/15/2015 3:37:50 PM
XBiotech USA, Inc. Announces Phase II Psoriasis Study Results in JAMA Dermatology 3/5/2015 6:51:18 AM
Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus 9/25/2014 7:32:18 AM
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results 9/2/2014 1:11:00 PM
XBiotech USA, Inc. Enrolls First Patient In Phase III European Registration Study Using Xilonix™ For Treatment Of Colorectal Cancer 8/4/2014 6:37:40 AM
123